This article explains: what GLP-1 drugs accomplish what they cannot fix why microbiome repair is essential for long-term results how to build metabolic stability from the inside out If you missed earlier GLP-1 blogs, start here: Microbiome Controls Appetite and Metabolism Natural GLP-1 Support: Fiber, SCFAs, Akkermansia Resetting Metabolism: Microbiome, SCFAs and GLP-1 Frequently Asked Questions GLP-1 Drugs, Microbiome Repair & Long-Term Metabolic Health: 1
It would be hoped that the societal benefit of these new drugs is to be combined with similar innovations in delivery that lead to scalable, reusable autoinjector solutions that ensure that the millions of patients, and the environments they live in, have a healthy and more sustainable outlook to 2030 and beyond
Sodium-Glucose Co-Transporter-2 Inhibitors Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are currently licensed for the treatment of T2D, though there is a growing body of evidence to support their use in cardiovascular [56] and renal disease [57]
This scented body lotion turns every application into a self-care ritual, a body lotion moisturizing experience to love